TLR9 has been particularly well studied in liver pathologies, and high quantities of mtDNA capable of activating TLR9 have been discovered in the plasma of humans and mice with NASH [61, 74]. This evidence concerns the gene TLR9 and metabolic dysfunction-associated steatohepatitis.